4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000146
Chairperson & CEO sold 9,500 shares at an average $494.55 ($4,698,271)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-21 | Sale : show line 2 in the form 10b5-1 | −1,520 | $492.97 | $749,321 | 332,423 | I |
| 2026-09-21 | Sale : show line 3 in the form 10b5-1 | −2,680 | $493.60 | $1,322,851 | 329,743 | I |
| 2026-09-21 | Sale : show line 4 in the form 10b5-1 | −2,170 | $494.82 | $1,073,751 | 327,573 | I |
| 2026-09-21 | Sale : show line 5 in the form 10b5-1 | −2,287 | $495.71 | $1,133,694 | 325,286 | I |
| 2026-09-21 | Sale : show line 6 in the form 10b5-1 | −843 | $496.62 | $418,654 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $494.55 · $4,698,271 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-21 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option | −9,500 | 394,910 | I |
Loading xslF345X06/primarydocument.xml…